H.C. Wainwright Bullish on Altimmune Amid Focus on Metabolic and Liver Diseases

H.C. Wainwright expresses a bullish sentiment on Altimmune (ALT) as the company gains increasing attention for its treatments targeting metabolic and liver diseases.